Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 14/20 | 0.53 |
| ▸ | HTR2A | P28223 | 3/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.48 |
| ▸ | DRD2 | P14416 | 3/20 | 0.48 |
| ▸ | DRD1 | P21728 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | DRD4 | P21917 | 2/20 | 0.48 |
| ▸ | DRD5 | P21918 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | DRD3 | P35462 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17050031 | 0.87 | TAAR1 (0.43) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL15805935 | 0.85 | TAAR1 (0.42) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL8337999 | 0.85 | TAAR1 (0.64) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL537203 | 0.85 | TAAR1 (0.60) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL207150 | 0.85 | TAAR1 (0.44) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL28837338 | 0.85 | TAAR1 (0.44) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5374338 | 0.83 | TAAR1 (0.42) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL659100 | 0.81 | TAAR1 (0.70) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL18469205 | 0.81 | TAAR1 (0.43) | TAAR1HTR2ACYP2A6LOXL2SMN1; SMN2 | |
| SCHEMBL7435676 | 0.79 | MAOA (0.48) | HTR2ACYP2A6CYP2D6CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116019933-A | Nano material for starvation treatment combined copper death as well as preparation method and application thereof | 南京邮电大学 | 2023-04-28 | — | — | CN | claimed |
| CN-116019933-A | Nano material for starvation treatment combined copper death as well as preparation method and application thereof | 南京邮电大学 | 2023-04-28 | — | — | CN | disclosed |
| US-9665069-B2 | Electric generator device, timepiece movement, and timepiece | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-05-30 | — | — | US | disclosed |
| US-9586907-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-03-07 | — | — | US | disclosed |
| US-20160170377-A1 | ELECTRIC GENERATOR DEVICE, TIMEPIECE MOVEMENT, AND TIMEPIECE | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-06-16 | — | — | US | disclosed |
| EP-2916449-A1 | VIBRATORY GENERATOR DEVICE AND POWER SOURCE MODULE | Asahi Glass Company, Limited (JP) | 2015-09-09 | — | — | EP | disclosed |
| US-20150246887-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2015-09-03 | — | — | US | disclosed |
| US-20150236619-A1 | VIBRATORY GENERATOR DEVICE AND POWER SOURCE MODULE | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-08-20 | — | — | US | disclosed |
| CN-104769833-A | Vibratory generator device and power source module | ASAHI GLASS CO LTD | 2015-07-08 | — | — | CN | disclosed |
| US-8859798-B2 | Isothiocyanate compounds, pharmaceutical compositions, and uses thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2014-10-14 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2009-11-26 | — | — | US | disclosed |
| EP-2104662-A2 | CHELATING AGENTS | GE Healthcare AS (NO) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008085064-A2 | HYDROXYPYRIDINONE CHELATING AGENTS, THEIR METAL COMPLEXES AND THEIR USE AS MRI CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2008-07-17 | — | — | WO | disclosed |
| US-6063819-A | PROTECTING NEURONS FROM DAMAGE BY ADMINISTERING TO HUMANS POLYGUADINO COMPOUNDS | CYPROS PHARMACEUTICAL CORP. (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0856542-A1 | Polyolefin polymer with good mechanical properties | DSM N.V. (NL) | 1998-08-05 | — | — | EP | disclosed |
| EP-0856545-A1 | Polyolefin polymer with high molecular weight | DSM N.V. (NL) | 1998-08-05 | — | — | EP | disclosed |
| EP-0707611-B1 | PROCESS FOR THE PREPARATION OF A DENDRITIC MACROMOLECULE | DSM NV (NL) | 1997-09-10 | — | — | EP | disclosed |
| EP-0707611-A1 | PROCESS FOR THE PREPARATION OF A DENDRITIC MACROMOLECULE | DSM NV (NL) | 1996-04-24 | — | — | EP | disclosed |
| WO-1995002008-A1 | PROCESS FOR THE PREPARATION OF A DENDRITIC MACROMOLECULE | DSM N.V. (NL) | 1995-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246887-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | TAAR1 3233/4885HTR2A 4229/4885CYP2A6 2211/4885 |
| US-20090291989-A1 | ISOTHIOCYANATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | TST, TREH, NFATC1 | TAAR1 3233/4885HTR2A 4229/4885CYP2A6 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.